US Stock MarketDetailed Quotes
DRRX Durect
- 0.9800
- +0.0578+6.27%
Trading Nov 19 13:06 ET
30.42MMarket Cap-1531P/E (TTM)
1.0800High0.9322Low134.70KVolume0.9500Open0.9222Pre Close135.80KTurnover0.45%Turnover RatioLossP/E (Static)31.04MShares1.880052wk High25.13P/B29.13MFloat Cap0.481052wk Low--Dividend TTM29.72MShs Float185.0000Historical High--Div YieldTTM16.03%Amplitude0.4703Historical Low1.0080Avg Price1Lot Size
About Durect Company
DURECT Corp. focuses on advancing novel and potentially lifesaving investigational therapies derived from its Epigenetic Regulator Program. Its pipeline is called DUR-928, an endogenous sulfated oxysterol and an epigenetic regulator. The company was founded by James E. Brown and Felix Theeuwes on February 6, 1998 and is headquartered in Cupertino, CA.
Company Profile
SymbolDRRX
Company NameDurect
Listing DateSep 28, 2000
Issue Price12.00
Founded1998
CEOMr. James E. Brown,D.V.M.
MarketNASDAQ
Employees58
Fiscal Year Ends12-31
Address10240 Bubb Road
CityCupertino
ProvinceCalifornia
CountryUnited States of America
Zip Code95014-4166
Phone1-408-777-1417
Websitehttp://www.durect.com
Company Executives
- Name
- Position
- Salary
- James E. Brown,D.V.M.
- President, Chief Executive Officer and Director
- 1.45M
- Timothy M. Papp, M.B.A.
- Chief Financial Officer and Principal Accounting Officer
- 671.31K
- Dr. Norman L. Sussman, M.D.
- Chief Medical Officer
- 654.48K
- Jian Li
- Interim Principal Accounting Officer, Senior Vice President, Finance, Corporate Controller and Secretary
- --
- Gail J. Maderis, M.B.A.
- Chairman of the Board
- 109.74K
- Judith J. Robertson
- Independent Director
- 83.12K
- Dr. Terrence F. Blaschke, M.D.
- Independent Director
- 83.12K
- Dr. Mohammad Azab, M.B.A.,M.D.,M.Sc.
- Independent Director
- 81.62K
- Dr. Gail M. Farfel, PhD
- Independent Director
- 70.62K
- Peter S. Garcia, M.B.A.
- Independent Director
- 84.73K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
